Logo image of CDIO

CARDIO DIAGNOSTICS HOLDINGS (CDIO) Stock Analyst Ratings

USA - NASDAQ:CDIO - US14159C2026 - Common Stock

3.86 USD
0 (0%)
Last: 11/10/2025, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CDIO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 61.2. This target is 1485.49% above the current price.
CDIO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CDIO.
In the previous month the buy percentage consensus was at a similar level.
CDIO was analyzed by 7 analysts. More opinions would make the average more meaningful.
CDIO Historical Analyst RatingsCDIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -34 -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 3.8660.6061.2061.2063.00 - 1,469.95% 1,485.49% 1,485.49% 1,532.12%
CDIO Current Analyst RatingCDIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-08-27 Benchmark Reiterate Speculative Buy -> Speculative Buy
2024-06-06 Benchmark Maintains Speculative Buy -> Speculative Buy
2024-04-19 Benchmark Maintains Speculative Buy -> Speculative Buy
2023-06-15 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-05-22 Northland Capital Markets Initiate Outperform
2023-04-18 Benchmark Reiterate Speculative Buy

CARDIO DIAGNOSTICS HOLDINGS / CDIO FAQ

What is the price target for CDIO stock?

7 analysts have analysed CDIO and the average price target is 61.2 USD. This implies a price increase of 1485.49% is expected in the next year compared to the current price of 3.86.


How do analysts rate CARDIO DIAGNOSTICS HOLDINGS (CDIO)?

The consensus rating for CARDIO DIAGNOSTICS HOLDINGS (CDIO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.